Overview

• The draft law mandates diagnosis by a multidisciplinary team and approval from a national pediatric ethics committee before any puberty blocker or hormone therapy can be administered to minors.
• An AIFA-managed national registry will log all prescriptions and dispensations of gender-affirming drugs with data sent to the Health Ministry every six months.
• The measure applies identical protocols to puberty blockers and hormone treatments without distinguishing between prepubescent and older minors.
• Trans rights activists and parent groups warn the registry amounts to an intrusive “schedatura,” risking patient privacy, delaying crucial care and prompting some families to seek treatment abroad.
• The bill stems from Senator Maurizio Gasparri’s parliamentary inquiry and spring inspections at Florence’s Careggi hospital, guided by international bioethical recommendations.